Detalles de la búsqueda
1.
Recommendations for reporting tissue and circulating tumour (ct)DNA next-generation sequencing results in non-small cell lung cancer.
Br J Cancer
; 2024 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38750115
2.
Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label, randomised controlled trial.
Lancet
; 402(10419): 2295-2306, 2023 12 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37931632
3.
The Use of Wearable Devices in Oncology Patients: A Systematic Review.
Oncologist
; 29(4): e419-e430, 2024 Apr 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37971410
4.
Matching-adjusted indirect comparison of amivantamab vs mobocertinib in platinum-pretreated EGFR Exon 20 insertion-mutated non-small-cell lung cancer.
Future Oncol
; 20(8): 447-458, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37882460
5.
Sensitive tumour detection and classification using plasma cell-free DNA methylomes.
Nature
; 563(7732): 579-583, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30429608
6.
Symptom screening with Targeted Early Palliative care (STEP) versus usual care for patients with advanced cancer: a mixed methods study.
Support Care Cancer
; 31(7): 404, 2023 Jun 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-37341839
7.
Integrating circulating-free DNA (cfDNA) analysis into clinical practice: opportunities and challenges.
Br J Cancer
; 127(4): 592-602, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35347327
8.
Utilization of Immunotherapy in Patients with Cancer Treated in Routine Care Settings: A Population-Based Study Using Health Administrative Data.
Oncologist
; 27(8): 675-684, 2022 08 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35552444
9.
A drug discovery platform to identify compounds that inhibit EGFR triple mutants.
Nat Chem Biol
; 16(5): 577-586, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32094923
10.
Surgery for malignant pleural mesothelioma after radiotherapy (SMART): final results from a single-centre, phase 2 trial.
Lancet Oncol
; 22(2): 190-197, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33450184
11.
Can Oncologists Predict the Efficacy of Treatments in Randomized Trials?
Oncologist
; 26(1): 56-62, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32936509
12.
Phase II Trial of Symptom Screening With Targeted Early Palliative Care for Patients With Advanced Cancer.
J Natl Compr Canc Netw
; 20(4): 361-370.e3, 2021 09 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34492632
13.
The impact of symptoms and comorbidity on health utility scores and health-related quality of life in small cell lung cancer using real world data.
Qual Life Res
; 30(2): 445-454, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-32851601
14.
Minimization of resource utilization data collected within cost-effectiveness analyses conducted alongside Canadian Cancer Trials Group phase III trials.
Clin Trials
; 18(4): 500-504, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33866856
15.
The financial impact of cancer care on renal cancer patients.
Can J Urol
; 28(4): 10762-10767, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34378512
16.
Biomarker-driven therapies for previously treated squamous non-small-cell lung cancer (Lung-MAP SWOG S1400): a biomarker-driven master protocol.
Lancet Oncol
; 21(12): 1589-1601, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33125909
17.
Value assessment of oncology drugs using a weighted criterion-based approach.
Cancer
; 126(7): 1530-1540, 2020 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31860138
18.
Development of the Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator (FACT-ICM): A toxicity subscale to measure quality of life in patients with cancer who are treated with ICMs.
Cancer
; 126(7): 1550-1558, 2020 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31914209
19.
Amplifying Outcomes: Checkpoint Inhibitor Combinations in First-Line Non-Small Cell Lung Cancer.
Oncologist
; 25(1): 64-77, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31138727
20.
Prolonging Survival: The Role of Immune Checkpoint Inhibitors in the Treatment of Extensive-Stage Small Cell Lung Cancer.
Oncologist
; 25(11): 981-992, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32860288